Wednesday’s 50th anniversary of Earth Day won’t be marked by widespread official rallies or demonstrations — such gatherings would be irresponsible during this global pandemic, even if they were allowed.
Congress must quickly reverse President Donald Trump’s defunding of the World Health Organization.
This should be a bipartisan priority, to provide U.S. leadership in combating the worldwide pandemic and support WHO’s broader, ongoing global-health mission.
The WHO made errors in its initial response to the coronavirus but so did Trump, who is scapegoating and undermining a critical health organization when it’s desperately needed to save lives.
UW infectious disease experts are volunteering to help conduct on-site COVID-19 tests and implement CDC prevention guidelines at senior living communities in the Seattle area where positive COVID-19 cases have been detected.
While the U.S. and Europe battle to slow the spread of the novel coronavirus, I can’t help but think about how Africa will cope when it becomes the next epicenter. Based on the three-month-old data that we have about the virus and its spread, guidelines on prevention, containment and mitigation have been set by the World Health Organization (WHO). So far, several African governments have adopted the U.S. and European approach that is centered on lockdowns, social distancing and frequent hand washing with soap and water.
The following is a transcript of an interview with Dr. Christopher Murray that aired Sunday, April 12, 2020, on "Face the Nation."
Even before the COVID-19 pandemic, health departments had limited staff, resources and time to support the diverse public health needs of our communities. This system will be further strained as the epidemic grows. We must immediately create a national public health reserve to shore up public health systems.
Things are still getting worse. The US death toll crossed 14,000 on Wednesday, with a record 1,858 deaths reported just on Tuesday. Since the outbreak started, about 425,000 cases have been diagnosed in the US. And researchers say the peak has yet to come.
The Coler Lab at Seattle Children’s Research Institute is using their expertise to support the clinical trial of an experimental coronavirus vaccine funded by National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. National Institutes of Health. The trial is being conducted at the Kaiser Permanente Washington Health Research Institute in Seattle, part of NIAID’s Infectious Diseases Clinical Research Consortium.
The benefits of hydroxychloroquine being investigated in multi-site clinical trial launching in April
Researchers are investigating whether hydroxychloroquine – a commonly used anti-malarial and autoimmune drug – can prevent COVID-19.
A multi-site clinical trial, led by the University of Washington Department of Global Health/International Clinical Research Center (ICRC) in collaboration with NYU Grossman School of Medicine, aims to definitively determine whether hydroxychloroquine can prevent transmission in people exposed to the virus.
In a forecast based on new data analyses, researchers find demand for ventilators and beds in US hospital intensive care units (ICUs) will far exceed capacity for COVID-19 patients as early as the second week of April. Deaths related to the current wave of COVID-19 in the US are likely to persist into July, even assuming people protect themselves and their communities by strongly adhering to social distancing measures and by taking other precautions advised by public health officials.